Inactive Instrument

Other languages EQRx, Inc.

Equities

EQRX

US26886C1071

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Revolution Medicines Closes Acquisition of EQRx in All-Stock Deal	Nov. 09
EQRx, Inc. Announces Board Resignations	Nov. 09
Revolution Medicines, Inc. completed the acquisition of EQRx, Inc. from a group of shareholders.	Nov. 08
Revolution Medicines, EQRx Stockholders Approve Merger	Nov. 08
EQRx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06
EQRx, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
EQRx, Inc. Provides Written Notice to G1 Therapeutics of its Termination of the Exclusive License Agreement	23-08-03
EQRx, Inc. Provides Written Notice to Hansoh Healthtech Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Company Ltd. of Its Termination of the Strategic Collaboration License Agreement	23-08-03
Revolution Medicines Shares Rise After Accord to Acquire EQRx in All-Stock Deal	23-08-01
Sector Update: Health Care Stocks Decline Premarket Tuesday	23-08-01
Sector Update: Health Care	23-08-01
Revolution Medicines Agrees to Acquire EQRx in All-Stock Deal	23-08-01
CStone Pharmaceuticals to Regain Commercialization Rights to Cancer Treatments	23-05-08
EQRx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08
EQRx, Inc. Announces Termination of Termination of the Exclusive License Agreement	23-05-08
EQRx Finance Chief Jami Rubin to Step Down	23-03-13
EQRx Posts Q4 Net Loss; Expects Cash Runway Into 2028	23-02-23
EQRx, Inc. Plans to Decrease 18% Headcount	23-02-23
EQRx, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-23
UK Regulator Accepts CStone Pharma's Marketing Authorization Application for Lung Cancer Treatment	22-12-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages EQRx, Inc.

Equities

EQRX

US26886C1071

Other languages

Filters